[Anti-aggregation therapy for prevention of cerebral ischemic stroke: a risk benefit analysis].
Zarranz Imirizaldu
J J
JJ
Servicio y Cátedra de Neurología, Hospital de Cruces, Baracaldo, Vizcaya.
D001241:Aspirin / Q000627:therapeutic use*; D002545:Brain Ischemia / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012306:Risk; D013988:Ticlopidine / Q000627:therapeutic use*
D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin
Tratamiento antiagregante para la prevención de los ictus cerebrales isquémicos: un análisis de beneficio/riesgo.